Alternative data datasets
Browse by provider, category, marketplace, access, delivery and license
View source information and access options.
Documentation covering the historical emergence of pharmacy as a recognized profession.
Monitor the intellectual property filings that influence pharmaceutical innovation and competition.
Exhaustive registry of locations linked to clinical research studies conducted worldwide.
An extensive repository containing records on more than 300,000 clinical studies involving pharmaceuticals and biologics.
A curated, well-organized collection of documents formatted for straightforward ingestion into retrieval-augmented generation systems.
View source information and access options.
View source information and access options.
30 pharma companies × 17 years, 722 drug approvals, 600 clinical trials
Clinical Trials Data Ingestion & ETL Pipeline -ClinicalTrials.gov API v2
Thirty-three opt-in prescription intent indicators drawn from roughly 38 million American individuals.
Clinical Trials Version History The Clinical Trials Version History dataset by Anamnesis Data: structured medical and scientific data for biotech, pharma and healthcare research. Public trial registries show only a trial's latest state. This dataset keeps every version, so you can see what a trial said on any past date, or when a sponsor moved a completion date. 606,620 trials (4,456,781 versions)
Clinical Trials Version History: Sample A free sample of the Clinical Trials Version History dataset by Anamnesis Data: structured medical and scientific data for biotech, pharma and healthcare research. Public trial registries show only a trial's latest state. This dataset keeps every version, so you can see what a trial said on any past date, or when a sponsor moved a completion date. The sample
Pharmacy-level prescription fill records tracking medication volumes and competitive market positions.
This dataset has moved to anamnesis-data/clinical_trials_history. New releases are published there only; this repository is no longer updated. Access approvals do not carry over, so please request access on the new repository. Existing tags here (up to v2026.09.26) remain available for pinned use. ClinicalTrials.gov Version History A longitudinal, per-version snapshot of every protocol amendment e
Research and intelligence covering pharmaceutical products, clinical trials, patent filings and regulatory progress.
A registry and results database of more than 450,000 clinical trials worldwide, with protocols, sites, enrollment counts, outcomes and sponsor details, queryable through a free REST API and bulk downloads, the reference source for pharmaceutical pipeline tracking.
Every registered clinical study flattened to one row: phase, status, sponsor
A prominent trade publication serving pharmacists across the United Kingdom.
Targeted pharmaceutical dataset designed to assist in evaluating the value of a drug candidate.
Pharmaceutical dataset built to help recommend candidates appropriate for licensing partnerships.
Pharmaceutical market overview using product taxonomies to identify and prioritize prospective targets.
Information that guides drug indication selection by quantifying addressable market size and opportunity.
All-in-one dataset designed for evaluating the full market environment at the product or therapeutic indication level.
A broad overview of the pharmaceutical market intended to support trend analysis and forecasting.
Evaluation of a candidate product's primary attributes including therapeutic use, underlying technology, and biological mechanism.
Detailed energy datasets attributed to more than 30,000 publicly traded and privately held companies at both the corporate and asset levels.
Worldwide investigator directory containing more than 460,000 researcher records plus roughly 3 million U.S. physician profiles.
Coverage of worldwide mergers and acquisitions activity, including asset purchases, private equity transactions, equity and debt issuances, and sustainable-finance bond offerings.
Longitudinal pricing information at three different levels for benchmarking costs of therapies across regions and disease categories.
Yearly and quarterly pharmaceutical revenue figures along with analyst consensus projections, broken down by product, geography, and medical condition.
Forecasts and historical figures spanning five years cover market size and share for retail loans, credit cards, and deposits.
Merges traditional financial fundamentals with alternative data and detailed sector information for approximately 6,000 major corporations.
IQVIA's Pharmetrics medical-claims dataset marketed on Snowflake Marketplace, offering United States healthcare billing records for pharmaceutical and biotechnology research.
FDA-regulated products and events exposed as structured JSON: adverse drug-event reports, device recalls and registrations, labels, the NDC directory and food enforcement, used for pharmacovigilance and regulatory-risk screens.
Clinical-trials records combining structured metadata and narrative text, hundreds of thousands of studies in Parquet. An early read on pharmaceutical pipeline activity and trial design trends.
Projected procedure volumes paired with market-share metrics across hospital service lines.
A carefully assembled and contextualized feed of essential pharmaceutical intelligence.
Pharmacovigilance risk assessment scores tied to biological mechanisms, derived from FDA prescribing information, published research, and ongoing clinical studies.
Extensive United States pharmaceutical reference data is available to support regulatory, clinical safety, and research workflows.
Veeva CRM data capturing how life-sciences sales teams interact with healthcare professionals in the field.
A 10% sample of over 573,000 ClinicalTrials.gov studies augmented with AI-classified therapeutic areas, sponsor categorization, outcome groupings, and duration metrics, offered for portfolio and market landscape analysis.
Over 635,000 registered clinical studies from ClinicalTrials.gov together with a supplementary pharma intelligence table of roughly 1.06 million rows that map those trials to FDA drug approvals, distributed as part of an open data initiative for academic and personal use.